JournalTOCs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Subjects -> STATISTICS (Total: 130 journals)

The end of the list has been reached or no journals were found for your choice.

Most Followed Journals

Top Publishers

Top Subjects

Similar Journals

Pharmaceutical Statistics
Journal Prestige (SJR): 1.494

Citation Impact (citeScore): 1
Number of Followers: 15

Hybrid journal (It can contain Open Access articles)
ISSN (Print) 1539-1604 - ISSN (Online) 1539-1612
Published by John Wiley and Sons

[1763 journals]

Reflecting on Andy Grieve's influence and innovation: A personal
perspective
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Mike K. Smith
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 702-705, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2220
  Issue No: Vol. 21, No. 4 (2022)
The cross‐over of statistical thinking and practices: A pandemic
catalyst
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Andrew D. Garrett
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 778-789, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2221
  Issue No: Vol. 21, No. 4 (2022)
From innovative thinking to pharmaceutical industry implementation: Some
success stories
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Rosalind Walley; Nigel Brayshaw
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 712-719, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2222
  Issue No: Vol. 21, No. 4 (2022)
Viewpoint: Do not resurrect the two‐stage procedure
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Stephen Senn
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 808-814, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2224
  Issue No: Vol. 21, No. 4 (2022)
The design and analysis of vaccine trials for COVID‐19 for the
purpose of estimating efficacy
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Stephen Senn
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 790-807, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2226
  Issue No: Vol. 21, No. 4 (2022)
Simulation‐based sequential design
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Peter Müller; Yunshan Duan, Mauricio Garcia Tec
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 729-739, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2216
  Issue No: Vol. 21, No. 4 (2022)
Rationale for the update algorithm of the graphical approach to
sequentially rejective multiple test procedures
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Willi Maurer; Frank Bretz, Martin Posch
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 757-763, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2227
  Issue No: Vol. 21, No. 4 (2022)
Study‐design in pandemics: From surveillance and
performance‐evaluation to licensing and pharmacovigilance
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Sheila M. Bird
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 764-777, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2217
  Issue No: Vol. 21, No. 4 (2022)
The Acute Stroke Therapy by Inhibition of Neutrophils study – Key
features and impact
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Simon Kirby; Christy Chuang‐Stein
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 720-728, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2218
  Issue No: Vol. 21, No. 4 (2022)
Do statisticians count' A prior and posterior viewpoint
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Margaret Jones; Gemma Hodgson
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 706-711, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2229
  Issue No: Vol. 21, No. 4 (2022)
Informed decision‐making: Statistical methodology for surrogacy
evaluation and its role in licensing and reimbursement assessments
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Christopher J. Weir; Rod S. Taylor
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 740-756, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2219
  Issue No: Vol. 21, No. 4 (2022)
A note from the editors
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Stephen Senn; Mike K. Smith
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 700-700, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2242
  Issue No: Vol. 21, No. 4 (2022)
Issue Information
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 697-699, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2136
  Issue No: Vol. 21, No. 4 (2022)
Foreword
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Adrian Smith
  Abstract: Pharmaceutical Statistics, Volume 21, Issue 4, Page 701-701, July/August 2022.
  PubDate: 2022-07-12T12:00:00-07:00
  DOI: 10.1002/pst.2243
  Issue No: Vol. 21, No. 4 (2022)
Key considerations for choosing a statistical method to deal with
incomplete treatment adherence in pragmatic trials
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Md. Belal Hossain; Mohammad Ehsanul Karim
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-08-03T03:19:22-07:00
  DOI: 10.1002/pst.2258
Response to the letter to the editor regarding our article ‘statistical
methodology for highly variable compounds: A novel design approach for the
ofatumumab phase 2 bioequivalence study’
https://doi.org/10.1002/pst.2233
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Byron Jones; Bingbing Li, Morten Bagger, Alex Goodyear, Inga Ludwig
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-07-20T05:27:43-07:00
  DOI: 10.1002/pst.2254
Comments on “Statistical methodology for highly variable compounds: A
novel design approach for the Ofatumumab phase 2 bioequivalence study”
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Wanjie Sun; Donald J. Schuirmann, Stella Grosser
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-07-20T05:17:53-07:00
  DOI: 10.1002/pst.2255
Evaluating response‐adaptive randomization procedures for recurrent
events and terminal event data using a composite endpoint
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Yu‐Lin Mau; Pei‐Fang Su
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-07-19T06:39:29-07:00
  DOI: 10.1002/pst.2253
A Bayesian piecewise exponential phase II design for monitoring a
time‐to‐event endpoint
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Yun Qing; Peter F. Thall, Ying Yuan
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-07-18T10:33:46-07:00
  DOI: 10.1002/pst.2256
Left truncation in linked data: A practical guide to understanding left
truncation and applying it using SAS and R
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Yanling Jin; Thanh G. N. Ton, Devin Incerti, Sylvia Hu
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-07-17T06:40:17-07:00
  DOI: 10.1002/pst.2257
CUSUMIN: A cumulative sum interval design for cancer phase I dose finding
studies
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Tomoyoshi Hatayama; Seiichi Yasui
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-07-14T06:20:20-07:00
  DOI: 10.1002/pst.2247
Improving early phase oncology clinical trial design: A case study
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Alan J. Phillips; Timothy P. Clark
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-06-29T12:09:37-07:00
  DOI: 10.1002/pst.2252
Win ratio approach for analyzing composite time‐to‐event endpoint with
opposite treatment effects in its components
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Ran Liao; Sujatro Chakladar, Margaret Gamalo
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-06-29T02:19:24-07:00
  DOI: 10.1002/pst.2248
Estimators for handling COVID‐19‐related intercurrent events with a
hypothetical strategy
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Florian Lasch; Lorenzo Guizzaro
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-06-28T01:09:11-07:00
  DOI: 10.1002/pst.2244
Win statistics (win ratio, win odds, and net benefit) can complement one
another to show the strength of the treatment effect on time‐to‐event
outcomes
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Gaohong Dong; Bo Huang, Johan Verbeeck, Ying Cui, James Song, Margaret Gamalo‐Siebers, Duolao Wang, David C. Hoaglin, Yodit Seifu, Tobias Mütze, John Kolassa
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-06-27T01:24:01-07:00
  DOI: 10.1002/pst.2251
A semi‐mechanistic dose‐finding design in oncology using
pharmacokinetic/pharmacodynamic modeling
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Xiao Su; Yisheng Li, Peter Müller, Chia‐Wei Hsu, Haitao Pan, Kim‐Anh Do
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-06-24T01:44:37-07:00
  DOI: 10.1002/pst.2249
A MCP‐Mod approach to designing and analyzing survival trials with
potential non‐proportional hazards
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Xiaodong Luo; Yuan Sun, Zhixing Xu
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-06-23T03:59:52-07:00
  DOI: 10.1002/pst.2241
Propensity score matching and stratification using multiparty data without
pooling
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Jixian Wang; Roland Marion‐Gallois
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-06-22T10:54:35-07:00
  DOI: 10.1002/pst.2250
Weighted log‐rank test to compare two survival functions in the presence
of dependent censoring
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Philippe Flandre
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-06-16T04:03:56-07:00
  DOI: 10.1002/pst.2245
Confirmatory efficacy testing for individual dose–placebo comparisons
using serial gatekeeping procedure in dose‐finding trials with multiple
comparison procedures–modeling
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Yusuke Yamaguchi; Toshifumi Sugitani, Satoshi Yoshida, Kazushi Maruo
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-06-16T02:54:20-07:00
  DOI: 10.1002/pst.2246
Estimation of treatment effects in short‐term depression studies. An
evaluation based on the ICH E9(R1) estimands framework
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Marian Mitroiu; Steven Teerenstra, Katrien Oude Rengerink, Frank Pétavy, Kit C. B. Roes
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-06-09T05:42:54-07:00
  DOI: 10.1002/pst.2214
Optimal unplanned design modification in adaptive two‐stage trials
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Maximilian Pilz; Carolin Herrmann, Geraldine Rauch, Meinhard Kieser
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-05-23T09:00:31-07:00
  DOI: 10.1002/pst.2228
Statistical methodology for highly variable compounds: A novel design
approach for the Ofatumumab Phase 2 bioequivalence study
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Byron Jones; Bingbing Li, Morten Bagger, Alex Goodyear, Inga Ludwig
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-05-23T08:10:16-07:00
  DOI: 10.1002/pst.2233
Empirical likelihood inference for area under the receiver operating
characteristic curve using ranked set samples
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Chul Moon; Xinlei Wang, Johan Lim
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-05-20T04:28:53-07:00
  DOI: 10.1002/pst.2230
Standard and reference‐based conditional mean imputation
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Marcel Wolbers; Alessandro Noci, Paul Delmar, Craig Gower‐Page, Sean Yiu, Jonathan W. Bartlett
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-05-19T03:28:44-07:00
  DOI: 10.1002/pst.2234
The utilities and pitfalls of stratified analysis in challenging
situations
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Jin Wang
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-05-16T06:22:53-07:00
  DOI: 10.1002/pst.2232
2 stage subgroup‐specific time‐to‐event (2S‐Sub‐TITE): An
adaptive two‐stage time‐to‐toxicity design for subgroup‐specific
dose finding in phase I oncology trials
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Alana McGovern; Andrew G. Chapple, Clement Ma
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-05-12T11:59:53-07:00
  DOI: 10.1002/pst.2231
A Bayesian latent class model for predicting gestational age in health
administrative data
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Shuang Wang; Gavino Puggioni, Xuerong Wen
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-05-10T05:00:29-07:00
  DOI: 10.1002/pst.2225
Practical guide to sample size calculations: Installation of the app
SampSize
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Laura Flight; Steven A. Julious
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-05-10T03:34:43-07:00
  DOI: 10.1002/pst.2215
Doubly‐robust methods for differences in restricted mean lifetimes using
pseudo‐observations
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Sangbum Choi; Taehwa Choi, Hye‐Young Lee, Sung Won Han, Dipankar Bandyopadhyay
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-05-07T02:54:57-07:00
  DOI: 10.1002/pst.2223
A flexible mixed data model applied to claims data for post‐market
surveillance of prescription drug safety behavior
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Harris Butler; John D. Rice, Nichole E. Carlson, Elaine H. Morrato
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-04-03T08:37:42-07:00
  DOI: 10.1002/pst.2213
Eliciting judgements about dependent quantities of interest: The SHeffield
ELicitation Framework extension and copula methods illustrated using an
asthma case study
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Björn Holzhauer; Lisa V. Hampson, John Paul Gosling, Björn Bornkamp, Joseph Kahn, Markus R. Lange, Wen‐Lin Luo, Caterina Brindicci, David Lawrence, Steffen Ballerstedt, Anthony O'Hagan
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-04-03T06:28:14-07:00
  DOI: 10.1002/pst.2212
Treatment‐specific marginal structural Cox model for the effect of
treatment discontinuation
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Dana Johnson; Karen Pieper, Shu Yang
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-03-31T03:09:47-07:00
  DOI: 10.1002/pst.2211
Confidence intervals for point‐of‐stabilization of content
uniformity
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Zdeněk Hlávka; Petr Míchal, Martin Otava
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-03-28T05:18:27-07:00
  DOI: 10.1002/pst.2207
Geometric approaches to assessing the numerical feasibility for conducting
matching‐adjusted indirect comparisons
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Ekkehard Glimm; Lillian Yau
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-03-28T04:02:42-07:00
  DOI: 10.1002/pst.2210
SCI: A Bayesian adaptive phase I/II dose‐finding design accounting for
semi‐competing risks outcomes for immunotherapy trials
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Yifei Zhang; Beibei Guo, Sha Cao, Chi Zhang, Yong Zang
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-03-24T10:57:57-07:00
  DOI: 10.1002/pst.2209
A two‐stage adaptive clinical trial design with data‐driven subgroup
identification at interim analysis
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Sarah E. Johnston; Ilya Lipkovich, Alex Dmitrienko, Yan Daniel Zhao
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-03-24T01:39:17-07:00
  DOI: 10.1002/pst.2208
Assessment of pharmacokinetic linearity after repeated drug administration
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Alexander Bauer; Matts Kagedal, Martin J. Wolfsegger
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-03-17T04:26:15-07:00
  DOI: 10.1002/pst.2206
The importance of using ordinal scores for patient classification based on
health‐related quality of life trajectories
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Antoine Barbieri; Florence Cousson‐Gélie, Louise Baussard, Sophie Gourgou, Christian Lavergne, Caroline Mollevi
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-03-15T04:43:17-07:00
  DOI: 10.1002/pst.2205
Bayesian adaptive randomization design incorporating propensity
score‐matched historical controls
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Ryo Sawamoto; Koji Oba, Yutaka Matsuyama
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-03-12T03:45:24-08:00
  DOI: 10.1002/pst.2203
Analysis of an incomplete binary outcome dichotomized from an underlying
continuous variable in clinical trials
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Chenchen Ma; Xin Shen, Yongming Qu, Yu Du
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-03-11T08:18:30-08:00
  DOI: 10.1002/pst.2204
Estimating survival parameters under conditionally independent left
truncation
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Arjun Sondhi
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-03-09T03:51:12-08:00
  DOI: 10.1002/pst.2202
Pairwise joint modeling of clustered and high‐dimensional outcomes with
covariate missingness in pediatric pneumonia care
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Susan Gachau; Edmund Njeru Njagi, Geert Molenberghs, Nelson Owuor, Rachel Sarguta, Mike English, Philip Ayieko
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-02-24T03:30:03-08:00
  DOI: 10.1002/pst.2197
Estimation and expected sample size in Simon's two stage designs that stop
as early as possible
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Antonios Daletzakis; Rutger Bor, Marianne A. Jonker, Kit C. B. Roes, Harm Tinteren
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-02-22T12:10:40-08:00
  DOI: 10.1002/pst.2200
Sample size re‐estimation for response‐adaptive randomized
clinical trials
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Xin Li; Feifang Hu
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-02-22T04:02:37-08:00
  DOI: 10.1002/pst.2199
Utilizing restricted mean duration of response for efficacy evaluation of
cancer treatments
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Bo Huang; Lu Tian
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-02-21T08:48:47-08:00
  DOI: 10.1002/pst.2198
Incorporating historical controls in clinical trials with longitudinal
outcomes using the modified power prior
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Hongchao Qi; Dimitris Rizopoulos, Emmanuel Lesaffre, Joost Rosmalen
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-02-06T09:48:53-08:00
  DOI: 10.1002/pst.2195
Estimands in observational studies: Some considerations beyond ICH E9 (R1)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Heng Li; Chenguang Wang, Wei‐Chen Chen, Nelson Lu, Changhong Song, Ram Tiwari, Yunling Xu, Lilly Q. Yue
  Abstract: Pharmaceutical Statistics, EarlyView.
  PubDate: 2022-02-06T08:58:06-08:00
  DOI: 10.1002/pst.2196